Neuland Laboratories Limited (NEULANDLAB) — share transfer | 2 July 2026

StockFin.ai

Try Free

📢 Key Event
Certificate under SEBI Regulation 74(5) submitted for Q1 FY27

💡 Investor Takeaway
This filing confirms routine compliance with SEBI's shareholding reporting rules, with no material changes or future implications disclosed.

Neuland Laboratories Limited received a SEBI-mandated certificate from its share transfer agent, Kfin Technologies Limited, confirming dematerialization/rematerialization details for the quarter ended June 30, 2026, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, and submitted to both NSE and BSE.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NEULANDLAB ✨ Ask AI About This

About Neuland Laboratories Limited (NEULANDLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹21,284.79 Cr P/E: 71.0

View full NEULANDLAB stock details →

📡 Get AI alerts when NEULANDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEULANDLAB — Free

💡 Ask AI about this filing

"How does this affect NEULANDLAB margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More NEULANDLAB filings

See all NEULANDLAB filings →

🔥 Also filed on 2 July 2026

CSBBANK CSB Bank Limited Insider Trading SWSOLAR Sterling and Wilson Renewable Energy Limited Announcement PSB Punjab & Sind Bank Annual Report CCCL Consolidated Construction Consortium Limited Annual Report TIMKEN Timken India Limited Corporate Action ZFCVINDIA ZF Commercial Vehicle Control Systems India Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when NEULANDLAB files new disclosures

Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NEULANDLAB — Free

Free account · 2 AI queries/day